Page
%P
10 Result(s)
within
L Wieczorek
Cancer Research
-
Article
Open AccessCross-clade neutralization of HIV-1 by a monoclonal antibody obtained by immunization with liposomes containing lipid A and a synthetic MPER peptide
-
Article
Open AccessAntigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development
-
Article
Open AccessImmunogenic selection of HIV-1 MPER epitopes for improved vaccine design
-
Article
Open AccessSoluble and bacteriophage T4 displayed gp41 mutant proteins as HIV-1 vaccine candidates
-
Article
Open AccessP04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
-
Article
Open AccessP04-22. Multispecific monoclonal antibodies bind to primary human macrophages and induce the production of protective chemokines, MIP-1α and MIP-1β
-
Article
Open AccessP19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
-
Article
Open AccessP05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
-
Article
Open AccessP04-19. Analysis of the binding of multiple clades of HIV-1 by a modified virus capture assay
-
Article
Open AccessP04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific
